Calyon sets up Asian DCM team and names leveraged finance head

Calyon has named a new Hong Kong-based debt capital markets (DCM) team for Asia excluding Japan, headed by Antoine Gros. The French bank has also appointed a new head of acquisition & leveraged finance for Asia excluding Japan.

Responsible for the development of a regional DCM platform, Gros will focus on products including high-yield bonds, flow and structured asset-backed securities (ABSs) and high-grade bonds. He started on September 1.

Gros has held several positions in Calyon’s fixed-income markets (FIM) division in London, New York and Paris, most recently as head of specialised assets securitisation for the Americas. In this New York-based role, he had responsibility for origination and execution of structured transactions and ABSs.

Calyon has also made three other DCM appointments in Hong Kong, reporting to Gros. Ralph Byun, previously head of the DCM business in Korea, becomes executive director of DCM for Asia excluding Japan; Agatha Cheung joins Calyon as director of DCM from Standard Chartered’s DCM team covering Greater China; and Elaine Kwan moves from ABN Amro’s DCM team as associate director of DCM.

Meanwhile, Calyon has appointed Julian Ostheim as Hong Kong-based head of acquisition & leveraged finance for Asia excluding Japan, and Kenney Cheung assumes the newly created position of director in Ostheim's team.

Ostheim joins from Calyon’s Frankfurt office, where he has been an executive director in the leveraged finance team for the past three years. He replaces Christophe Cerisier, who left the bank in April.

Cheung was previously at DBS in Hong Kong, where he was vice-president of syndicated finance, focusing on leveraged finance origination.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here